Stratos
| Characteristic | Group1 |
| Group 2 |
|
| Group 3 |
|
| |||
| Age @ |
| N=42 |
| N=50 |
| N=25 |
|
| |||
| Enrollment (Yrs) |
|
|
| 0.534* |
| ||||||
| Mean ± SE | 73.7 ± 1.3 |
| 72.3 ± 1.2 |
| 71.5 ± 1.6 |
|
| ||||
|
|
|
|
|
| |||||||
| Range | 56 to 90 | 51 to 86 |
| 52 to 85 |
|
| |||||
| Gender |
| N=42 |
| N=50 |
| N=25 |
|
| |||
| Male | 18 | (42.9%) |
| 19 | (38.0%) |
| 13 (52.0%) |
| 0.553** |
| |
| Female | 24 | (57.1%) |
| 31 | (62.0%) |
| 12 (48.0%) |
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
| |
| Distance |
| N=42 |
| N=50 |
| N=25 |
|
| |||
| (meters) |
|
|
| 0.395* |
| ||||||
| Mean ± SE | 262.7 ± |
| 283.6 ± |
| 267.8 ± |
|
| ||||
|
|
|
|
|
| |||||||
| Range |
| 15.1 |
|
| 13.8 |
| 22.9 |
|
|
| |
|
| 78 to 420 | 37 to 438 |
| 23 to 420 |
|
| |||||
| New York Heart |
|
|
|
|
|
|
|
|
|
|
|
| Association |
| N=42 |
| N=50 |
| N=25 | 0.189** |
| |||
| Class |
|
|
|
| |||||||
| Class II | 23 | (54.8%) |
| 18 | (36.0%) |
| 10 (40.0%) |
|
|
| |
| Class III | 19 | (45.2%) |
| 32 | (64.0%) |
| 15 (60.0%) |
|
|
| |
| Underlying Heart |
| N=42 |
| N=49 |
| N=25 |
|
| |||
| Disease |
|
|
| 0.125** |
| ||||||
| Dilated | 8 (19.0%) |
| 11 | (22.4%) |
| 1 (4.0%) |
|
| |||
| Cardiomyopathy | 4 | (9.5%) |
| 1 | (2.0%) |
| 2 (8.0%) |
| 0.216** |
| |
| Hypertrophic |
|
|
|
| |||||||
| Cardiomyopathy | 12 | (28.6%) |
| 12 | (24.5%) |
| 5 (20.0%) |
| 0.792** |
| |
| Valvular Heart |
|
|
|
| |||||||
| Disease | 19 | (45.2%) |
| 28 | (57.7%) |
| 6 (24.0%) |
| 0.031** |
| |
| Coronary Artery |
|
|
|
| |||||||
| Disease | 37 | (88.1%) |
| 37 | (75.5%) |
| 19 (76.0%) |
| 0.348** |
| |
| Hypertension |
|
|
|
| |||||||
| No underlying | 3 | (7.1%) |
| 2 | (4.1%) |
| 7 (28.0%) |
| 0.007** |
| |
| structural heart |
|
|
|
|
|
|
|
|
|
|
|
| disease |
|
|
|
|
|
|
|
|
|
|
|